397 related articles for article (PubMed ID: 25601314)
21. Effects of cosmetics containing purified honeybee (Apis mellifera L.) venom on acne vulgaris.
Han SM; Lee KG; Pak SC
J Integr Med; 2013 Sep; 11(5):320-6. PubMed ID: 24063779
[TBL] [Abstract][Full Text] [Related]
22. Topical acne treatments in Europe and the issue of antimicrobial resistance.
Leccia MT; Auffret N; Poli F; Claudel JP; Corvec S; Dreno B
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1485-92. PubMed ID: 25677763
[TBL] [Abstract][Full Text] [Related]
23. Pentobra: A Potent Antibiotic with Multiple Layers of Selective Antimicrobial Mechanisms against Propionibacterium Acnes.
Schmidt NW; Agak GW; Deshayes S; Yu Y; Blacker A; Champer J; Xian W; Kasko AM; Kim J; Wong GCL
J Invest Dermatol; 2015 Jun; 135(6):1581-1589. PubMed ID: 25668237
[TBL] [Abstract][Full Text] [Related]
24. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes.
Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N
J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility of Propionibacterium acnes and Staphylococcus epidermidis to killing by MPO-halide system products. Implication for taurine bromamine as a new candidate for topical therapy in treating acne vulgaris.
Marcinkiewicz J; Biedroń R; Białecka A; Kasprowicz A; Mak M; Targosz M
Arch Immunol Ther Exp (Warsz); 2006; 54(1):61-8. PubMed ID: 16642259
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of two plant extracts against acne vulgaris: Initial results of microbiological tests and cell culture studies.
Kılıç S; Okullu SÖ; Kurt Ö; Sevinç H; Dündar C; Altınordu F; Türkoğlu M
J Cosmet Dermatol; 2019 Aug; 18(4):1061-1065. PubMed ID: 30414245
[TBL] [Abstract][Full Text] [Related]
27. Topical tetracycline in the treatment of acne vulgaris.
Adişen E; Kaymak Y; Gurer MA; Durukan E
J Drugs Dermatol; 2008 Oct; 7(10):953-5. PubMed ID: 19112759
[TBL] [Abstract][Full Text] [Related]
28. Development and Characterization of an Anti-Acne Gel Containing Siamese Crocodile (
Phupiewkham W; Lu Q; Payoungkiattikun W; Temsiripong T; Jangpromma N; Lai R; Klaynongsruang S
J Microbiol Biotechnol; 2018 May; 28(5):707-717. PubMed ID: 29807397
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of adapalene 0.1% / benzoyl peroxide 2.5% in the long-term treatment of predominantly moderate acne with or without concomitant medication - results from the non-interventional cohort study ELANG.
Gollnick HP; Friedrich M; Peschen M; Pettker R; Pier A; Streit V; Jöstingmeyer P; Porombka D; Rojo Pulido I; Jäckel A
J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 4():15-22. PubMed ID: 26059730
[TBL] [Abstract][Full Text] [Related]
30. Biopolymer scaffolds for use in delivering antimicrobial sophorolipids to the acne-causing bacterium Propionibacterium acnes.
Ashby RD; Zerkowski JA; Solaiman DK; Liu LS
N Biotechnol; 2011 Jan; 28(1):24-30. PubMed ID: 20708720
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
Richter JR; Förström LR; Kiistala UO; Jung EG
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic resistance of microbial strains isolated from Korean acne patients.
Moon SH; Roh HS; Kim YH; Kim JE; Ko JY; Ro YS
J Dermatol; 2012 Oct; 39(10):833-7. PubMed ID: 22779738
[TBL] [Abstract][Full Text] [Related]
33. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.
Pollock B; Turner D; Stringer MR; Bojar RA; Goulden V; Stables GI; Cunliffe WJ
Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.
Nakatsuji T; Kao MC; Fang JY; Zouboulis CC; Zhang L; Gallo RL; Huang CM
J Invest Dermatol; 2009 Oct; 129(10):2480-8. PubMed ID: 19387482
[TBL] [Abstract][Full Text] [Related]
35. Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan.
Nakase K; Nakaminami H; Takenaka Y; Hayashi N; Kawashima M; Noguchi N
J Med Microbiol; 2014 May; 63(Pt 5):721-728. PubMed ID: 24523159
[TBL] [Abstract][Full Text] [Related]
36. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review.
Patel M; Bowe WP; Heughebaert C; Shalita AR
J Drugs Dermatol; 2010 Jun; 9(6):655-64. PubMed ID: 20645527
[TBL] [Abstract][Full Text] [Related]
37. Fluorescence photography in the evaluation of acne.
Lucchina LC; Kollias N; Gillies R; Phillips SB; Muccini JA; Stiller MJ; Trancik RJ; Drake LA
J Am Acad Dermatol; 1996 Jul; 35(1):58-63. PubMed ID: 8682965
[TBL] [Abstract][Full Text] [Related]
38. Cathelicidin-BF, a snake cathelicidin-derived antimicrobial peptide, could be an excellent therapeutic agent for acne vulgaris.
Wang Y; Zhang Z; Chen L; Guang H; Li Z; Yang H; Li J; You D; Yu H; Lai R
PLoS One; 2011; 6(7):e22120. PubMed ID: 21789223
[TBL] [Abstract][Full Text] [Related]
39. In vitro activities of azole antifungal agents against Propionibacterium acnes isolated from patients with acne vulgaris.
Sugita T; Miyamoto M; Tsuboi R; Takatori K; Ikeda R; Nishikawa A
Biol Pharm Bull; 2010; 33(1):125-7. PubMed ID: 20045949
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P
Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
